Journal Article Review Epublish 9 citations
PubMed: 37317282 DOI: 10.3390/microorganisms11051308
Strategies for the Management of Spike Protein-Related Pathology.
Microorganisms 11(5)
Authors: Matthew T J Halma, Christof Plothe, Paul Marik, Theresa A Lawrie
Affiliations
- EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UK.
- Center for Biophysical Osteopathy, Am Wegweiser 27, 55232 Alzey, Germany.
- Front Line COVID-19 Critical Care Alliance (FLCCC), 2001 L St. NW Suite 500, Washington, DC 20036, USA.
Abstract
In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.
MeSH
Pathology, Thrombosis, Autophagy, Covid-19 Vaccines
Cited by
- The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury. Adv Virol, 2025
- Human PBMCs Form Lipid Droplets in Response to Spike Proteins. Microorganisms, 2023